<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:64d33e80-b9cb-4119-a851-4185edcd7d34,g:6c76df34-156e-4b35-a64d-356ee2701381-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="rnac-20250630.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_d52bec2a-b264-4e0d-a9a5-892e5f3267ba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_1bd5f057-afbc-4235-8c7e-0ffcfd462060" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d52bec2a-b264-4e0d-a9a5-892e5f3267ba" xlink:to="loc_us-gaap_Liabilities_1bd5f057-afbc-4235-8c7e-0ffcfd462060" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_3bb4b579-b5f6-4fd3-98a3-8e9f8ac4213b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d52bec2a-b264-4e0d-a9a5-892e5f3267ba" xlink:to="loc_us-gaap_StockholdersEquity_3bb4b579-b5f6-4fd3-98a3-8e9f8ac4213b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_fd93f6b2-c787-4802-903a-3a30016ee0b4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d52bec2a-b264-4e0d-a9a5-892e5f3267ba" xlink:to="loc_us-gaap_CommitmentsAndContingencies_fd93f6b2-c787-4802-903a-3a30016ee0b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_de25854f-d107-4cf4-b789-924f551f9aa8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_6b50d524-f80f-47ca-83ae-4e8ab8194577" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_de25854f-d107-4cf4-b789-924f551f9aa8" xlink:to="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_6b50d524-f80f-47ca-83ae-4e8ab8194577" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_7af86e12-b549-4b4a-b3e3-0c5235cc9286" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_de25854f-d107-4cf4-b789-924f551f9aa8" xlink:to="loc_us-gaap_AccountsPayableCurrent_7af86e12-b549-4b4a-b3e3-0c5235cc9286" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ContingentValueRightLiabilityCurrent_fc525c1d-3194-4b04-8867-727546669226" xlink:href="rnac-20250630.xsd#rnac_ContingentValueRightLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_de25854f-d107-4cf4-b789-924f551f9aa8" xlink:to="loc_rnac_ContingentValueRightLiabilityCurrent_fc525c1d-3194-4b04-8867-727546669226" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_32d1013d-d5b4-4327-a079-a77efdf25396" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_de25854f-d107-4cf4-b789-924f551f9aa8" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_32d1013d-d5b4-4327-a079-a77efdf25396" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_785ddd46-8f8f-4a6c-b80e-f2c187996afe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_7fbaa08e-7839-4716-bb16-dc5aafdbc234" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_785ddd46-8f8f-4a6c-b80e-f2c187996afe" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_7fbaa08e-7839-4716-bb16-dc5aafdbc234" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_a1e76cea-c0a1-4415-8aa7-6839c15fdf76" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_785ddd46-8f8f-4a6c-b80e-f2c187996afe" xlink:to="loc_us-gaap_Goodwill_a1e76cea-c0a1-4415-8aa7-6839c15fdf76" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_ebb22908-ddf4-4f68-9219-24414cebdb05" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_785ddd46-8f8f-4a6c-b80e-f2c187996afe" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_ebb22908-ddf4-4f68-9219-24414cebdb05" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_fa83d44f-b5bc-49da-9782-9a46f4c2da93" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_785ddd46-8f8f-4a6c-b80e-f2c187996afe" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_fa83d44f-b5bc-49da-9782-9a46f4c2da93" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_421b3701-b113-483f-a104-fc1b4f2c485c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_785ddd46-8f8f-4a6c-b80e-f2c187996afe" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_421b3701-b113-483f-a104-fc1b4f2c485c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_49f7f6d2-eb45-4216-af72-ace03147924f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_785ddd46-8f8f-4a6c-b80e-f2c187996afe" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_49f7f6d2-eb45-4216-af72-ace03147924f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_3e15d4c2-deb3-41b0-b078-6ac13032e590" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_785ddd46-8f8f-4a6c-b80e-f2c187996afe" xlink:to="loc_us-gaap_AssetsCurrent_3e15d4c2-deb3-41b0-b078-6ac13032e590" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_ab2c2037-00c4-4b34-81e7-855644740057" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_785ddd46-8f8f-4a6c-b80e-f2c187996afe" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_ab2c2037-00c4-4b34-81e7-855644740057" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_d960d0d7-f04e-4a98-b9bf-e56bc4b388f0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_691fa839-fd7f-471c-8586-a8f9d2c834ff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d960d0d7-f04e-4a98-b9bf-e56bc4b388f0" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_691fa839-fd7f-471c-8586-a8f9d2c834ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3189686b-8cee-40d9-b1ab-64fbb3b48139" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d960d0d7-f04e-4a98-b9bf-e56bc4b388f0" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3189686b-8cee-40d9-b1ab-64fbb3b48139" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_b99c7d38-7416-4ac4-bac0-4ea142a808d2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d960d0d7-f04e-4a98-b9bf-e56bc4b388f0" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_b99c7d38-7416-4ac4-bac0-4ea142a808d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_53716430-9cde-4b3d-a4ae-57f3ebcd4e43" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1bfb2612-a89e-43a1-9400-d56965a77acc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_53716430-9cde-4b3d-a4ae-57f3ebcd4e43" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1bfb2612-a89e-43a1-9400-d56965a77acc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_535a85da-a29a-4ba9-8c75-a4404562e4e5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_53716430-9cde-4b3d-a4ae-57f3ebcd4e43" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_535a85da-a29a-4ba9-8c75-a4404562e4e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_bd501e37-6aa8-4c0e-b679-381789c4ef89" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_53716430-9cde-4b3d-a4ae-57f3ebcd4e43" xlink:to="loc_us-gaap_LiabilitiesCurrent_bd501e37-6aa8-4c0e-b679-381789c4ef89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ContingentValueRightLiabilityNoncurrent_5db5d8aa-92fa-4f1b-9c0d-17a37f02b431" xlink:href="rnac-20250630.xsd#rnac_ContingentValueRightLiabilityNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_53716430-9cde-4b3d-a4ae-57f3ebcd4e43" xlink:to="loc_rnac_ContingentValueRightLiabilityNoncurrent_5db5d8aa-92fa-4f1b-9c0d-17a37f02b431" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_WarrantsAndRightsOutstandingNoncurrent_6acfdccc-a8e8-436c-a64c-094bfb2e5ab6" xlink:href="rnac-20250630.xsd#rnac_WarrantsAndRightsOutstandingNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_53716430-9cde-4b3d-a4ae-57f3ebcd4e43" xlink:to="loc_rnac_WarrantsAndRightsOutstandingNoncurrent_6acfdccc-a8e8-436c-a64c-094bfb2e5ab6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_bf37f630-f5b6-444a-9521-c7ea34974dc5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_c36f7f69-8bb4-4a13-a02a-79c7da0747d2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_bf37f630-f5b6-444a-9521-c7ea34974dc5" xlink:to="loc_us-gaap_CommonStockValue_c36f7f69-8bb4-4a13-a02a-79c7da0747d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3636bbf0-565a-4dae-a7f1-188da8b91958" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_bf37f630-f5b6-444a-9521-c7ea34974dc5" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3636bbf0-565a-4dae-a7f1-188da8b91958" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_bd9fd2fd-4fa7-411d-a8f0-9f6f094b24d9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_bf37f630-f5b6-444a-9521-c7ea34974dc5" xlink:to="loc_us-gaap_PreferredStockValue_bd9fd2fd-4fa7-411d-a8f0-9f6f094b24d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_6763e364-fce8-4bde-99bc-abd520bf849d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_bf37f630-f5b6-444a-9521-c7ea34974dc5" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_6763e364-fce8-4bde-99bc-abd520bf849d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_fe558760-d661-415b-82b7-db0d76dae7d4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_bf37f630-f5b6-444a-9521-c7ea34974dc5" xlink:to="loc_us-gaap_AdditionalPaidInCapital_fe558760-d661-415b-82b7-db0d76dae7d4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="simple" xlink:href="rnac-20250630.xsd#ConsolidatedStatementsofOperationsandComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_d9d5ecf9-ac88-4c8a-8896-accece1732f7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_7d1a444c-0b9a-4c67-98b1-5160bacca85a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_d9d5ecf9-ac88-4c8a-8896-accece1732f7" xlink:to="loc_us-gaap_NetIncomeLoss_7d1a444c-0b9a-4c67-98b1-5160bacca85a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_e581a21e-7977-4bbd-ae79-bbf761ff6009" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_d9d5ecf9-ac88-4c8a-8896-accece1732f7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_e581a21e-7977-4bbd-ae79-bbf761ff6009" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_8fc12913-f092-4836-8be3-33734f460d67" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6f15a03a-cead-41a3-8be4-22c41ebe0bf5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_8fc12913-f092-4836-8be3-33734f460d67" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6f15a03a-cead-41a3-8be4-22c41ebe0bf5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer_a9d3b69e-7c89-4563-bb5c-511392b29f15" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_8fc12913-f092-4836-8be3-33734f460d67" xlink:to="loc_us-gaap_RevenueNotFromContractWithCustomer_a9d3b69e-7c89-4563-bb5c-511392b29f15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_63abd46c-49cc-4409-a484-1f67dda3aed1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_cf423b63-7022-4715-84ff-e5c5c94c7d41" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_63abd46c-49cc-4409-a484-1f67dda3aed1" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_cf423b63-7022-4715-84ff-e5c5c94c7d41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_379d63dd-d81c-478b-a3da-a8111d0089dc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_63abd46c-49cc-4409-a484-1f67dda3aed1" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_379d63dd-d81c-478b-a3da-a8111d0089dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_86a6acbf-d94a-47b7-9e78-279f5d23ae58" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_c9c08efc-974e-4633-af4c-61f269583712" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_86a6acbf-d94a-47b7-9e78-279f5d23ae58" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_c9c08efc-974e-4633-af4c-61f269583712" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_fca4e5f2-8a57-4e07-a17f-638b43d01021" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_86a6acbf-d94a-47b7-9e78-279f5d23ae58" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_fca4e5f2-8a57-4e07-a17f-638b43d01021" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ddb36f78-a290-4b9f-b55a-bf106aaa4c49" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_86a6acbf-d94a-47b7-9e78-279f5d23ae58" xlink:to="loc_us-gaap_OperatingIncomeLoss_ddb36f78-a290-4b9f-b55a-bf106aaa4c49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_18bf7f2d-1259-41e3-a367-27cc9a73240d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_86a6acbf-d94a-47b7-9e78-279f5d23ae58" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_18bf7f2d-1259-41e3-a367-27cc9a73240d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_881c95c0-581a-4769-bc9b-cb17246ad89c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_86a6acbf-d94a-47b7-9e78-279f5d23ae58" xlink:to="loc_us-gaap_InvestmentIncomeNet_881c95c0-581a-4769-bc9b-cb17246ad89c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_FairValueAdjustmentOfContingentValueRightLiability_6dfde517-38a9-4f89-8464-792e180e7a12" xlink:href="rnac-20250630.xsd#rnac_FairValueAdjustmentOfContingentValueRightLiability"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_86a6acbf-d94a-47b7-9e78-279f5d23ae58" xlink:to="loc_rnac_FairValueAdjustmentOfContingentValueRightLiability_6dfde517-38a9-4f89-8464-792e180e7a12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_d85b1917-85c8-45e4-909a-93a331551ad1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_1e18e985-e506-467d-89bc-83fde57e0819" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_d85b1917-85c8-45e4-909a-93a331551ad1" xlink:to="loc_us-gaap_OperatingExpenses_1e18e985-e506-467d-89bc-83fde57e0819" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_c5360ca1-4640-4d4f-9b67-b2c938a13073" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_d85b1917-85c8-45e4-909a-93a331551ad1" xlink:to="loc_us-gaap_Revenues_c5360ca1-4640-4d4f-9b67-b2c938a13073" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="rnac-20250630.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_89d789ae-17f6-433a-9f92-7d474b2fbb79" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_059ccd25-9d58-41cc-a230-4fbc19e53591" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_89d789ae-17f6-433a-9f92-7d474b2fbb79" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_059ccd25-9d58-41cc-a230-4fbc19e53591" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c14d3c34-3dd2-43d7-8680-dfceea05dd1b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1df94b4f-4dd8-4d33-96ac-726be843b7ff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c14d3c34-3dd2-43d7-8680-dfceea05dd1b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1df94b4f-4dd8-4d33-96ac-726be843b7ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_83eb3f5d-5722-4502-a62e-21c2ababb25c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c14d3c34-3dd2-43d7-8680-dfceea05dd1b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_83eb3f5d-5722-4502-a62e-21c2ababb25c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0d907450-f74d-4ad4-80e5-93a42f42b96a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c14d3c34-3dd2-43d7-8680-dfceea05dd1b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0d907450-f74d-4ad4-80e5-93a42f42b96a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b2609bb6-07cc-4723-bfb8-22b51b115a48" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c14d3c34-3dd2-43d7-8680-dfceea05dd1b" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b2609bb6-07cc-4723-bfb8-22b51b115a48" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_77fe3785-3d04-4b76-84fa-8bd04a74b4c7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_34a38e34-70c7-4f67-88c3-7707f559c0ef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_77fe3785-3d04-4b76-84fa-8bd04a74b4c7" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_34a38e34-70c7-4f67-88c3-7707f559c0ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_ed375889-5da8-4388-a15e-7386f3b7cd13" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_77fe3785-3d04-4b76-84fa-8bd04a74b4c7" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_ed375889-5da8-4388-a15e-7386f3b7cd13" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_63c15733-d1b5-4d89-8912-5bf772dafdd5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_77fe3785-3d04-4b76-84fa-8bd04a74b4c7" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_63c15733-d1b5-4d89-8912-5bf772dafdd5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_da79b0fd-0217-407c-bdd1-284318e7643a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_77fe3785-3d04-4b76-84fa-8bd04a74b4c7" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_da79b0fd-0217-407c-bdd1-284318e7643a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_14ac3e0e-cdb1-4735-b4fc-1025e2e52f84" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_77fe3785-3d04-4b76-84fa-8bd04a74b4c7" xlink:to="loc_us-gaap_NetIncomeLoss_14ac3e0e-cdb1-4735-b4fc-1025e2e52f84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_c34fc972-e97c-4884-bc42-794028992399" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_77fe3785-3d04-4b76-84fa-8bd04a74b4c7" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_c34fc972-e97c-4884-bc42-794028992399" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_cdc474de-893d-4442-a46e-1462910ea9cd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_77fe3785-3d04-4b76-84fa-8bd04a74b4c7" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_cdc474de-893d-4442-a46e-1462910ea9cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_b0422f0f-3e76-4ca1-933d-b508c3649aad" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_77fe3785-3d04-4b76-84fa-8bd04a74b4c7" xlink:to="loc_us-gaap_ShareBasedCompensation_b0422f0f-3e76-4ca1-933d-b508c3649aad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDepreciationAndAmortization_cfe3dab4-6c94-494d-bf7c-42a3a740e11f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_77fe3785-3d04-4b76-84fa-8bd04a74b4c7" xlink:to="loc_us-gaap_OtherDepreciationAndAmortization_cfe3dab4-6c94-494d-bf7c-42a3a740e11f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_c47b87b3-7de7-429c-814a-5f38da719e83" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_77fe3785-3d04-4b76-84fa-8bd04a74b4c7" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_c47b87b3-7de7-429c-814a-5f38da719e83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_8206785f-6404-4ab9-b559-ca9b2faae48d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_77fe3785-3d04-4b76-84fa-8bd04a74b4c7" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_8206785f-6404-4ab9-b559-ca9b2faae48d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_FairValueAdjustmentOfContingentValueRightLiability_04cfa59b-6f17-42b2-baf9-54fa7373cfc2" xlink:href="rnac-20250630.xsd#rnac_FairValueAdjustmentOfContingentValueRightLiability"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_77fe3785-3d04-4b76-84fa-8bd04a74b4c7" xlink:to="loc_rnac_FairValueAdjustmentOfContingentValueRightLiability_04cfa59b-6f17-42b2-baf9-54fa7373cfc2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_ed7cfee8-1134-42ef-9708-46bcc013ddb9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_77fe3785-3d04-4b76-84fa-8bd04a74b4c7" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_ed7cfee8-1134-42ef-9708-46bcc013ddb9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_IncreaseDecreaseInContractWithCustomerAssetAllowanceForCreditLossCurrent_472cc217-a3e1-4d54-861c-8f65c5bea786" xlink:href="rnac-20250630.xsd#rnac_IncreaseDecreaseInContractWithCustomerAssetAllowanceForCreditLossCurrent"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_77fe3785-3d04-4b76-84fa-8bd04a74b4c7" xlink:to="loc_rnac_IncreaseDecreaseInContractWithCustomerAssetAllowanceForCreditLossCurrent_472cc217-a3e1-4d54-861c-8f65c5bea786" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_95528fc1-c8ee-4e1f-aa47-1e707d97bc91" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_c7a6aa8f-6b5e-46e1-a3e6-45ce3083c5ca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_95528fc1-c8ee-4e1f-aa47-1e707d97bc91" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_c7a6aa8f-6b5e-46e1-a3e6-45ce3083c5ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_8194185a-be55-4688-bafc-c14e4ea3b5ca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_95528fc1-c8ee-4e1f-aa47-1e707d97bc91" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_8194185a-be55-4688-bafc-c14e4ea3b5ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_5aa363d4-27ef-4e88-b339-88e7ace97219" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_95528fc1-c8ee-4e1f-aa47-1e707d97bc91" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_5aa363d4-27ef-4e88-b339-88e7ace97219" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_PaymentsForContingentValueRightsDistributions_2ea80660-2ca2-4b1d-a9ec-4d4e21350601" xlink:href="rnac-20250630.xsd#rnac_PaymentsForContingentValueRightsDistributions"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_95528fc1-c8ee-4e1f-aa47-1e707d97bc91" xlink:to="loc_rnac_PaymentsForContingentValueRightsDistributions_2ea80660-2ca2-4b1d-a9ec-4d4e21350601" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_5de591c5-30d5-4b80-b1c5-90297aa59590" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_95528fc1-c8ee-4e1f-aa47-1e707d97bc91" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_5de591c5-30d5-4b80-b1c5-90297aa59590" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/NetIncomeLossPerShareAllocabletoCommonStockholdersScheduleofComputationofBasicandDilutedNetIncomeLossPerShareAllocabletoCommonStockholdersDetails" xlink:type="simple" xlink:href="rnac-20250630.xsd#NetIncomeLossPerShareAllocabletoCommonStockholdersScheduleofComputationofBasicandDilutedNetIncomeLossPerShareAllocabletoCommonStockholdersDetails"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/NetIncomeLossPerShareAllocabletoCommonStockholdersScheduleofComputationofBasicandDilutedNetIncomeLossPerShareAllocabletoCommonStockholdersDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b6f8e94b-19b4-4763-bdef-9c2fe7e7fe5f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_32c6a2ff-6acc-4613-b638-6473626dbf7f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b6f8e94b-19b4-4763-bdef-9c2fe7e7fe5f" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_32c6a2ff-6acc-4613-b638-6473626dbf7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_8a024e40-4609-4355-b682-58e32e8a8f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b6f8e94b-19b4-4763-bdef-9c2fe7e7fe5f" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_8a024e40-4609-4355-b682-58e32e8a8f8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_8c0bcaaa-fd17-4c7a-b457-cbb62c628243" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_70e87b2c-10ff-43c1-aa87-f5e098f10f3e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_8c0bcaaa-fd17-4c7a-b457-cbb62c628243" xlink:to="loc_us-gaap_NetIncomeLoss_70e87b2c-10ff-43c1-aa87-f5e098f10f3e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_4883b43e-0005-4bab-bb27-a2a7c84b7970" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_8c0bcaaa-fd17-4c7a-b457-cbb62c628243" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_4883b43e-0005-4bab-bb27-a2a7c84b7970" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_316a1088-7220-4530-8cb8-1e69b85a9fb3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_29e1123c-cfe6-4758-b5ef-6ad10fdd5e84" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_316a1088-7220-4530-8cb8-1e69b85a9fb3" xlink:to="loc_us-gaap_NetIncomeLoss_29e1123c-cfe6-4758-b5ef-6ad10fdd5e84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_72a6a750-14b5-4b84-a892-0c18a0a0669c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_316a1088-7220-4530-8cb8-1e69b85a9fb3" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_72a6a750-14b5-4b84-a892-0c18a0a0669c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="rnac-20250630.xsd#FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_437dbf89-8ef9-4dea-af22-b5198cbda9bd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_5836c53c-7050-40b6-b3ad-91d2eeca2510" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_437dbf89-8ef9-4dea-af22-b5198cbda9bd" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_5836c53c-7050-40b6-b3ad-91d2eeca2510" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_2f1a2faf-f5d3-4949-a797-1a9d8e577b24" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_2e179de6-f5d9-4c4c-82c6-70c2e188e8bd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_2f1a2faf-f5d3-4949-a797-1a9d8e577b24" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_2e179de6-f5d9-4c4c-82c6-70c2e188e8bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ContingentValueRightLiability_3fa9ebc7-fdc3-4b23-8af3-a39f7e31083a" xlink:href="rnac-20250630.xsd#rnac_ContingentValueRightLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_2f1a2faf-f5d3-4949-a797-1a9d8e577b24" xlink:to="loc_rnac_ContingentValueRightLiability_3fa9ebc7-fdc3-4b23-8af3-a39f7e31083a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="rnac-20250630.xsd#FairValueMeasurementsScheduleofCashCashEquivalentsandRestrictedCashDetails"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_40dc4e8b-2a29-4cf0-8304-09e548cc7ace" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_d479c3c0-11d7-4e6c-8202-7acb5199fa24" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_40dc4e8b-2a29-4cf0-8304-09e548cc7ace" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_d479c3c0-11d7-4e6c-8202-7acb5199fa24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_da9ca406-8200-455c-8e8b-f4458d5b17ed" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_40dc4e8b-2a29-4cf0-8304-09e548cc7ace" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_da9ca406-8200-455c-8e8b-f4458d5b17ed" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="rnac-20250630.xsd#PropertyandEquipmentScheduleofPropertyandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_d7665e0f-55bd-4425-9976-c125d255f29a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_42221f51-7167-4ea2-a5d2-2c15efc52c97" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_d7665e0f-55bd-4425-9976-c125d255f29a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_42221f51-7167-4ea2-a5d2-2c15efc52c97" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_3b6d7ac7-7022-4ac9-a3e6-7aa4749330b1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_d7665e0f-55bd-4425-9976-c125d255f29a" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_3b6d7ac7-7022-4ac9-a3e6-7aa4749330b1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/AccruedExpensesDetails" xlink:type="simple" xlink:href="rnac-20250630.xsd#AccruedExpensesDetails"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/AccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_ffae6244-e3f0-4262-adc8-1586f36796ce" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_6dc4a577-0eeb-402e-836d-41fb858096e8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_ffae6244-e3f0-4262-adc8-1586f36796ce" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_6dc4a577-0eeb-402e-836d-41fb858096e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_AccruedResearchAndDevelopmentCostsCurrent_2311bff3-2c86-4e98-a36b-09c8e74ea891" xlink:href="rnac-20250630.xsd#rnac_AccruedResearchAndDevelopmentCostsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_ffae6244-e3f0-4262-adc8-1586f36796ce" xlink:to="loc_rnac_AccruedResearchAndDevelopmentCostsCurrent_2311bff3-2c86-4e98-a36b-09c8e74ea891" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_AccruedPropertyPlantAndEquipmentCurrent_99856eab-c9d4-4edf-98cc-883c4f749315" xlink:href="rnac-20250630.xsd#rnac_AccruedPropertyPlantAndEquipmentCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_ffae6244-e3f0-4262-adc8-1586f36796ce" xlink:to="loc_rnac_AccruedPropertyPlantAndEquipmentCurrent_99856eab-c9d4-4edf-98cc-883c4f749315" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_AccruedAuditFeesCurrent_7d7de27b-0a2d-4f0d-bf8f-a499b4ea4c1a" xlink:href="rnac-20250630.xsd#rnac_AccruedAuditFeesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_ffae6244-e3f0-4262-adc8-1586f36796ce" xlink:to="loc_rnac_AccruedAuditFeesCurrent_7d7de27b-0a2d-4f0d-bf8f-a499b4ea4c1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_AccruedPatentFeesCurrent_efa9e7d8-5fe6-4670-ad0d-ae969f47c8c5" xlink:href="rnac-20250630.xsd#rnac_AccruedPatentFeesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_ffae6244-e3f0-4262-adc8-1586f36796ce" xlink:to="loc_rnac_AccruedPatentFeesCurrent_efa9e7d8-5fe6-4670-ad0d-ae969f47c8c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_1c735cee-96c6-4e59-96b9-af1a1cf4c778" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_ffae6244-e3f0-4262-adc8-1586f36796ce" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_1c735cee-96c6-4e59-96b9-af1a1cf4c778" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/LeasesScheduleofComponentsofLeaseCostsDetails" xlink:type="simple" xlink:href="rnac-20250630.xsd#LeasesScheduleofComponentsofLeaseCostsDetails"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/LeasesScheduleofComponentsofLeaseCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_59702c08-3e6e-442c-a98d-6fc8483d68df" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_200ee5ac-e990-413e-9638-3b2bb4b1f93f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_59702c08-3e6e-442c-a98d-6fc8483d68df" xlink:to="loc_us-gaap_OperatingLeaseCost_200ee5ac-e990-413e-9638-3b2bb4b1f93f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_85114879-838f-45af-8e77-d1e0333498a1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VariableLeaseCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_59702c08-3e6e-442c-a98d-6fc8483d68df" xlink:to="loc_us-gaap_VariableLeaseCost_85114879-838f-45af-8e77-d1e0333498a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_10ec02b0-41af-447b-b330-daa545aab1b0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_59702c08-3e6e-442c-a98d-6fc8483d68df" xlink:to="loc_us-gaap_ShortTermLeaseCost_10ec02b0-41af-447b-b330-daa545aab1b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_fce657d7-f55d-4a9b-b55b-efd4cd846acb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubleaseIncome"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_59702c08-3e6e-442c-a98d-6fc8483d68df" xlink:to="loc_us-gaap_SubleaseIncome_fce657d7-f55d-4a9b-b55b-efd4cd846acb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/LeasesScheduleofMaturityofOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="rnac-20250630.xsd#LeasesScheduleofMaturityofOperatingLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/LeasesScheduleofMaturityofOperatingLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3197a5ca-0842-4a6e-b32c-00dbc4d86dd0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_5cf4a6da-4ed0-47cf-84be-ce912ee2ea5c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3197a5ca-0842-4a6e-b32c-00dbc4d86dd0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_5cf4a6da-4ed0-47cf-84be-ce912ee2ea5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_32e04396-2798-4df5-b49c-68b3f98c5b16" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3197a5ca-0842-4a6e-b32c-00dbc4d86dd0" xlink:to="loc_us-gaap_OperatingLeaseLiability_32e04396-2798-4df5-b49c-68b3f98c5b16" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/LeasesScheduleofMaturityofOperatingLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="rnac-20250630.xsd#LeasesScheduleofMaturityofOperatingLeaseLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/LeasesScheduleofMaturityofOperatingLeaseLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_dde422a5-4877-4809-92b7-e2234ae2a498" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_3b6633d0-8214-4e31-9d14-536ea04a92a6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_dde422a5-4877-4809-92b7-e2234ae2a498" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_3b6633d0-8214-4e31-9d14-536ea04a92a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c0c196b6-13c7-4e8a-9d52-09123574ca1f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_dde422a5-4877-4809-92b7-e2234ae2a498" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c0c196b6-13c7-4e8a-9d52-09123574ca1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_d91fbc28-119e-432b-8535-b5bd6c4aa7c3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_dde422a5-4877-4809-92b7-e2234ae2a498" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_d91fbc28-119e-432b-8535-b5bd6c4aa7c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_3c984549-52ae-47b0-9360-ff8bf85a608c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_dde422a5-4877-4809-92b7-e2234ae2a498" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_3c984549-52ae-47b0-9360-ff8bf85a608c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_50f136a4-1ff4-4725-93fc-2d640d2266cc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_dde422a5-4877-4809-92b7-e2234ae2a498" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_50f136a4-1ff4-4725-93fc-2d640d2266cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_c4a3964e-7cf8-4edb-92bc-62dadff9da32" xlink:href="rnac-20250630.xsd#rnac_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_dde422a5-4877-4809-92b7-e2234ae2a498" xlink:to="loc_rnac_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_c4a3964e-7cf8-4edb-92bc-62dadff9da32" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/SegmentReportingDetails" xlink:type="simple" xlink:href="rnac-20250630.xsd#SegmentReportingDetails"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/SegmentReportingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_67c32fcb-1057-42d5-9020-4bd53777cd3c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_07d21d21-aebf-4240-be30-8df9d1b94f20" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_67c32fcb-1057-42d5-9020-4bd53777cd3c" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_07d21d21-aebf-4240-be30-8df9d1b94f20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_df52d1d6-c886-4344-9397-942c48c57f72" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_67c32fcb-1057-42d5-9020-4bd53777cd3c" xlink:to="loc_us-gaap_Revenues_df52d1d6-c886-4344-9397-942c48c57f72" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_41859878-64bf-4b00-85ba-c4a058b501a4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_67c32fcb-1057-42d5-9020-4bd53777cd3c" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_41859878-64bf-4b00-85ba-c4a058b501a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_5f1b3004-bd63-4b6d-9ef3-9303ded82a58" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_67c32fcb-1057-42d5-9020-4bd53777cd3c" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_5f1b3004-bd63-4b6d-9ef3-9303ded82a58" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
